WHO. Obesity and overweight 2024 [updated March 1, 2024; cited June 27, 2024]. Available from: https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight.

Hruby A, Manson JE, Qi L, et al. Determinants and consequences of obesity. Am J Public Health. 2016;106(9):1656–62.

Article  PubMed  PubMed Central  Google Scholar 

Arroyo-Johnson C, Mincey KD. Obesity epidemiology worldwide. Gastroenterol Clin North Am. 2016;45(4):571–9.

Article  PubMed  PubMed Central  Google Scholar 

WHO. Obesity : preventing and managing the global epidemic : report of a WHO consultation. World Health Organization 2000 [cited 2025]. Available from: https://iris.who.int/handle/10665/42330.

Shafiee A, Nakhaee Z, Bahri RA, et al. Global prevalence of obesity and overweight among medical students: a systematic review and meta-analysis. BMC Public Health. 2024;24(1):1673.

Article  PubMed  PubMed Central  Google Scholar 

Prospective Studies C. Body-mass index and cause-specific mortality in 900,000 adults: collaborative analyses of 57 prospective studies. The Lancet. 2009;373(9669):1083–96.

Jung UJ, Choi MS. Obesity and its metabolic complications: the role of adipokines and the relationship between obesity, inflammation, insulin resistance, dyslipidemia and nonalcoholic fatty liver disease. Int J Mol Sci. 2014;15(4):6184–223.

Article  PubMed  PubMed Central  Google Scholar 

Clemente-Postigo M, Queipo-Ortuño MI, Fernandez-Garcia D, et al. Adipose tissue gene expression of factors related to lipid processing in obesity. PLoS One. 2011;6(9):e24783.

Klop B, Elte JW, Cabezas MC. Dyslipidemia in obesity: mechanisms and potential targets. Nutrients. 2013;5(4):1218–40.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Kahn BB, Flier JS. Obesity and insulin resistance. J Clin Invest. 2000;106(4):473–81.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Lenz M, Richter T, Mühlhauser I. The morbidity and mortality associated with overweight and obesity in adulthood: a systematic review. Dtsch Arztebl Int. 2009;106(40):641–8.

PubMed  PubMed Central  Google Scholar 

Dinpanah K, Kazemi T, Shetty S, et al. The association of the apolipoprotein B/A1 ratio and the metabolic syndrome in children and adolescents: a systematic review and meta-analysis. J Diabetes Metab Disord. 2024;23(1):1–10.

Article  PubMed  CAS  Google Scholar 

Haji Aghajani M, Madani Neishaboori A, Ahmadzadeh K, et al. The association between apolipoprotein A-1 plasma level and premature coronary artery disease: a systematic review and meta-analysis. Int J Clin Pract. 2021;75(11).

Quercioli A, Montecucco F, Galan K, et al. Anti-apolipoprotein A-1 IgG levels predict coronary artery calcification in obese but otherwise healthy individuals. Mediators Inflamm. 2012;2012:243158.

Morita SY. Metabolism and modification of apolipoprotein B-containing lipoproteins involved in dyslipidemia and atherosclerosis. Biol Pharm Bull. 2016;39(1):1–24.

Article  PubMed  CAS  Google Scholar 

Nathir I, Abd Aziz F, Hashim R. Association between apolipoprotein B and coronary artery disease among hypertensive patients: a systematic review of the prospective and retrospective studies. Cureus. 2023;15(12): e49854.

PubMed  PubMed Central  Google Scholar 

Chou YC, Kuan JC, Bai CH, et al. Predictive value of serum apolipoprotein B/apolipoprotein A-I ratio in metabolic syndrome risk: a Chinese cohort study. Endocrine. 2015;49(2):404–14.

Article  PubMed  CAS  Google Scholar 

Sierra-Johnson J, Romero-Corral A, Somers VK, et al. ApoB/apoA-I ratio: an independent predictor of insulin resistance in US non-diabetic subjects. Eur Heart J. 2007;28(21):2637–43.

Article  PubMed  CAS  Google Scholar 

Yadav R, Hama S, Liu Y, et al. Effect of Roux-en-Y bariatric surgery on lipoproteins, insulin resistance, and systemic and vascular inflammation in obesity and diabetes. Front Immunol. 2017;8:1512.

Article  PubMed  PubMed Central  Google Scholar 

Castañer O, Pérez-Vega KA, Álvarez S, et al. Effect of bariatric surgery on HDL-mediated cholesterol efflux capacity. Front Cardiovasc Med. 2024;11:1469433.

Article  PubMed  PubMed Central  Google Scholar 

Pradel-Mora JJ, Marín G, Castillo-Rangel C, et al. Oxidative stress in postbariatric patients: a systematic literature review exploring the long-term effects of bariatric surgery. Plast Reconstr Surg. 2024;12(3):e5646.

Adam S, Ho JH, Liu Y, et al. Bariatric surgery leads to a reduction in antibodies to apolipoprotein A-1: a prospective cohort study. Obes Surg. 2022;32(2):355–64.

Article  PubMed  Google Scholar 

Iqbal Z, Bashir B, Adam S, et al. Glycated apolipoprotein B decreases after bariatric surgery in people with and without diabetes: a potential contribution to reduction in cardiovascular risk. Atherosclerosis. 2022;346:10–7.

Article  PubMed  CAS  Google Scholar 

Heneghan HM, Huang H, Kashyap SR, et al. Reduced cardiovascular risk after bariatric surgery is linked to plasma ceramides, apolipoprotein-B100, and ApoB100/A1 ratio. Surg Obes Relat Dis. 2013;9(1):100–7.

Article  PubMed  Google Scholar 

Lorkowski SW, Brubaker G, Rotroff DM, et al. Bariatric surgery improves HDL function examined by ApoA1 exchange rate and cholesterol efflux capacity in patients with obesity and type 2 diabetes. Biomolecules. 2020;10(4):551.

Article  PubMed  PubMed Central  CAS  Google Scholar 

MayoClinic. Bariatric surgery 2024 [cited 2025]. Available from: https://www.mayoclinic.org/tests-procedures/bariatric-surgery/about/pac-20394258.

Wei JH, Lee MH, Lee WJ, et al. Change of cardiovascular risk associated serologic biomarkers after gastric bypass: a comparison of diabetic and non-diabetic Asian patients. Asian J Surg. 2022;45(11):2253–8.

Article  PubMed  Google Scholar 

Zhao S, Hörkkö S, Savolainen MJ, et al. Short-term metabolic changes and their physiological mediators in the Roux-en-Y gastric bypass bariatric surgery. Obes Surg. 2024;34(2):625–34.

Article  PubMed  PubMed Central  Google Scholar 

Eriksson Hogling D, Bäckdahl J, Thorell A, et al. Metabolic impact of body fat percentage independent of body mass index in women with obesity remission after gastric bypass. Obes Surg. 2020;30(3):1086–92.

Article  PubMed  Google Scholar 

Genua I, Puig N, Miñambres I, et al. Changes in the composition and function of lipoproteins after bariatric surgery in patients with severe obesity. J Clin Med. 2021;10(8):1716.

Carlsson ER, Allin KH, Madsbad S, et al. Phosphatidylcholine and its relation to apolipoproteins A-1 and B changes after Roux-en-Y gastric bypass: a cohort study. Lipids Health Dis. 2019;18(1):169.

Article  PubMed  PubMed Central  Google Scholar 

Makaju HS, Sharma VK, Yadav BK, et al. Association of apolipoprotein B/apolipoprotein AI ratio with cardiometabolic risk biomarkers in type 2 diabetes mellitus. Res Square [preprint]. 2022.

He H, Feng J, Zhang S, et al. The apolipoprotein B/A1 ratio is associated with metabolic syndrome components, insulin resistance, androgen hormones, and liver enzymes in women with polycystic ovary syndrome. Front Endocrinol (Lausanne). 2021;12:773781.